Last updated on November 2018

Open-Label Extension and Safety Study of Talazoparib

Brief description of study

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Clinical Study Identifier: NCT02921919

Contact Investigators or Research Sites near you

Start Over

Pfizer Pfizer Call Center

UCLA Hematology/Oncology - Santa Clarita
Valencia, CA United States
  Connect »